Ioannis X.
- Country
- Greece
- Department
- 3rd Pediatric Department
Research Overview
- Evaluation of Filgotinib Efficacy, Safety, and Pharmacokinetics in Pediatric Patients with Moderate to Severe Ulcerative Colitis
- Evaluation of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Patients with Moderately to Severely Active Ulcerative Colitis
- Efficacy and Safety Evaluation of Esomeprazole Magnesium in Maintaining Healing of Erosive Esophagitis in Pediatric Patients Aged 1 to 11 Years
Data & Insights
Has run more than one trial at 32 of 84 partner sites.
Specializations
Inflammatory Bowel Disease (IBD) Research
This investigator specializes in treating pediatric patients with inflammatory bowel diseases, focusing particularly on Crohn's disease and ulcerative colitis in children and adolescents.
- Pediatric Crohn's Disease Management
- Ulcerative Colitis Treatment
- Novel Therapeutic Approaches
Their work involves evaluating innovative treatments including vedolizumab and filgotinib for young patients.
Pediatric Gastroenterology
The investigator demonstrates expertise in treating gastrointestinal disorders in children, with particular attention to erosive esophagitis and its maintenance therapy.
- Erosive Esophagitis Treatment
- Long-term Disease Management
- Pediatric Endoscopic Procedures
Their research includes evaluation of treatments for children aged 1 to 11 years with various gastrointestinal conditions.
Clinical Therapeutics
The investigator focuses on maintenance therapy approaches and long-term treatment outcomes in pediatric gastroenterological conditions.
- Treatment Efficacy Assessment
- Safety Profile Evaluation
- Therapeutic Drug Monitoring
Their research encompasses both induction and maintenance phases of treatment in pediatric populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.